1. Home
  2. INBS vs SYNX Comparison

INBS vs SYNX Comparison

Compare INBS & SYNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INBS
  • SYNX
  • Stock Information
  • Founded
  • INBS 2016
  • SYNX 2005
  • Country
  • INBS United States
  • SYNX Israel
  • Employees
  • INBS N/A
  • SYNX N/A
  • Industry
  • INBS Medical Specialities
  • SYNX
  • Sector
  • INBS Health Care
  • SYNX
  • Exchange
  • INBS Nasdaq
  • SYNX Nasdaq
  • Market Cap
  • INBS 11.7M
  • SYNX 11.4M
  • IPO Year
  • INBS N/A
  • SYNX 2024
  • Fundamental
  • Price
  • INBS $1.47
  • SYNX $1.73
  • Analyst Decision
  • INBS
  • SYNX
  • Analyst Count
  • INBS 0
  • SYNX 0
  • Target Price
  • INBS N/A
  • SYNX N/A
  • AVG Volume (30 Days)
  • INBS 188.1K
  • SYNX 96.1K
  • Earning Date
  • INBS 08-15-2025
  • SYNX 10-02-2025
  • Dividend Yield
  • INBS N/A
  • SYNX N/A
  • EPS Growth
  • INBS N/A
  • SYNX N/A
  • EPS
  • INBS N/A
  • SYNX N/A
  • Revenue
  • INBS $3,052,532.00
  • SYNX $9,094,000.00
  • Revenue This Year
  • INBS $280.88
  • SYNX $32.35
  • Revenue Next Year
  • INBS $126.26
  • SYNX N/A
  • P/E Ratio
  • INBS N/A
  • SYNX N/A
  • Revenue Growth
  • INBS N/A
  • SYNX 19.14
  • 52 Week Low
  • INBS $1.00
  • SYNX $1.50
  • 52 Week High
  • INBS $3.00
  • SYNX $6.49
  • Technical
  • Relative Strength Index (RSI)
  • INBS 41.02
  • SYNX 47.51
  • Support Level
  • INBS $1.42
  • SYNX $1.54
  • Resistance Level
  • INBS $1.53
  • SYNX $1.79
  • Average True Range (ATR)
  • INBS 0.09
  • SYNX 0.14
  • MACD
  • INBS -0.01
  • SYNX -0.00
  • Stochastic Oscillator
  • INBS 25.00
  • SYNX 55.49

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).

About SYNX Silynxcom Ltd.

Silynxcom Ltd is engaged in developing, manufacturing, marketing, and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat proved. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, markets, and sell push-to-talk devices, communication controllers, and communication device cables and connectors.

Share on Social Networks: